TG Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. TG Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 8290% to $233,662,000. The net income raised on $12,672,000 and profit margin reached 5%. Total operating expenses were $198,898,000.
Profit Margin
| 2014 | 152.38K | -55.78M | -36606.45% |
|---|---|---|---|
| 2015 | 152.38K | -62.94M | -41310.04% |
| 2016 | 152.38K | -78.25M | -51353.45% |
| 2017 | 152.38K | -118.47M | -77749.86% |
| 2018 | 152K | -173.48M | -114132.89% |
| 2019 | 152K | -179.34M | -117991.45% |
| 2020 | 152K | -285.87M | -188077.63% |
| 2021 | 6.68M | -355.55M | -5315.47% |
| 2022 | 2.78M | -203.83M | -7318.89% |
| 2023 | 233.66M | 12.67M | 5.42% |
0VGI.L Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 233.66M | 2.78M | 6.68M | 152K | 152K | 152K | 152.38K | 152.38K | 152.38K | 152.38K |
Cost of revenue | 14.55M | 265K | 790K | 374K | 282K | 88K | 82.35K | 62.96K | 0 | 0 |
Gross profit | 219.10M | 2.52M | 5.89M | -222K | -130K | 64K | 70.02K | 89.42K | 152.38K | 152.38K |
Operating exp. | ||||||||||
Research and development | 76.19M | 112.12M | 198.53M | 151.93M | 148.36M | 153.79M | 96.88M | 66.48M | 43.44M | 31.35M |
Selling and marketing | 0 | 64.04M | 90.86M | 41.52M | 0 | -5.59M | -5.64M | -2.74M | -4.26M | -8.73M |
Total operating expenses | 198.89M | 195.35M | 350.66M | 273.74M | 169.20M | 174.55M | 118.86M | 79.12M | 63.33M | 55.87M |
Operating income | 20.63M | -192.83M | -344.77M | -273.59M | -169.05M | -174.4M | -118.71M | -78.96M | -63.18M | -55.72M |
Other income (expenses), net | -7.57M | -5.49M | -3.33M | -5.78M | -3.81M | 61K | 235.98K | 393.20K | 231.37K | -60.18K |
Income before tax | 13.06M | -198.33M | -348.10M | -279.38M | -172.87M | -173.48M | -118.47M | -78.25M | -62.94M | -55.78M |
Income tax expense | 390K | 5.49M | 7.45M | 6.49M | 6.47M | -918K | -235.73K | -716.23K | -231.37K | 60.18K |
Net income | 12.67M | -203.83M | -355.55M | -285.87M | -179.34M | -173.48M | -118.47M | -78.25M | -62.94M | -55.78M |
Earnings per share | ||||||||||
Basic EPS | 0.08 | -1.51 | -2.69 | -2.48 | -2.03 | -2.3 | -1.91 | -1.6 | -1.38 | -1.64 |
Diluted EPS | 0.08 | -1.51 | -2.69 | -2.48 | -2.03 | -2.3 | -1.91 | -1.6 | -1.38 | -1.64 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |